Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jeffrey Thomas Mullaney is active.

Publication


Featured researches published by Jeffrey Thomas Mullaney.


Bioorganic & Medicinal Chemistry Letters | 2000

1,2-Disubstituted indole, azaindole and benzimidazole derivatives possessing amine moiety : A novel series of thrombin inhibitors

Kumiko Takeuchi; Jolie Anne Bastian; Donetta S. Gifford-Moore; Richard Waltz Harper; Shawn Christopher Miller; Jeffrey Thomas Mullaney; Daniel Jon Sall; Gerald F. Smith; Minsheng Zhang; Matthew Joseph Fisher

A novel series of 1,2-disubstituted indole, azaindole and benzimidazole derivatives possessing an amine moiety was identified as thrombin inhibitors. An indole with basic diamine moieties (12a) was the most potent thrombin inhibitor in the series with Kass= 197 x 10(6) L/mol.


Bioorganic & Medicinal Chemistry Letters | 2000

Fused bicyclic Gly-Asp β-turn mimics with potent affinity for GPIIb-IIIa. Exploration of the arginine isostere

Matthew Joseph Fisher; Ulrich Giese; Cathy S. Harms; Michael Dean Kinnick; Terry D. Lindstrom; Jefferson R. McCowan; Hans-Jürgen Mest; John Michael Morin; Jeffrey Thomas Mullaney; Michael Paal; Achim Rapp; Gerd Ruhter; Ken J. Ruterbories; Daniel Jon Sall; Robert M. Scarborough; Theo Schotten; Wolfgang Stenzel; Richard D. Towner; Suzane L. Um; Barbara G. Utterback; Virginia L. Wyss; Joseph A. Jakubowski

6-[4-Amidinobenzoyl]amino]-tetralone-2-acetic acid is a potent antagonist of GPIIb-IIIa. Substitution in the meta position of the benzamidine, or replacement with a heteroaryl amidine was tolerated in this series. Use of an acyl-linked 4-alkyl piperidine as an arginine isostere also provided active compounds. Compounds from this series provided substantial systemic exposure in the rat following oral administration.


Bioorganic & Medicinal Chemistry Letters | 1997

Dihydroisoquinolone RGD mimics. Exploration of the aspartate isostere

Matthew Joseph Fisher; Bruce P. Gunn; Cathy S. Harms; Allen D. Kline; Jeffrey Thomas Mullaney; Robert M. Scarborough; Marshall Alan Skelton; Suzane L. Um; Barbara G. Utterback; Joseph A. Jakubowski

Abstract Disubstituted 3,4-dihydroisoquinolones that contain an ether-linked benzamidine at C6 and a β-substituted aspartate mimic at C2 offer enhanced affinity for GPIIb–IIIa relative to the non-substituted isoquinolone propionate. Alkyl substituents afforded a 10-fold increase in intrinsic activity while aryl substituents yielded a 40-fold improvement.


Archive | 2000

Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists

Karin Briner; Joseph Paul Burkhart; Timothy Paul Burkholder; Brian Eugene Cunningham; Matthew Joseph Fisher; William Harlan Gritton; Shawn Christopher Miller; Jeffrey Thomas Mullaney; Matthew Robert Reinhard; Dennis Charles Thompson; Leonard L. Winneroski; Yanping Xu


Archive | 2002

Substituted piperidines/piperazines as melanocortin receptor agonists

Ryan T. Backer; Karin Briner; Christopher William Doecke; Matthew Joseph Fisher; Steven L. Kuklish; Vincent Mancuso; Michael J. Martinelli; Jeffrey Thomas Mullaney; Chaoyu Xie


Archive | 1996

Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation

Matthew Joseph Fisher; Joseph A. Jakubowski; John Joseph Masters; Jeffrey Thomas Mullaney; Michael Paal; Gerd Ruhter; Kenneth J. Ruterbories; Robert M. Scarborough; Theo Schotten; Wolfgang Stenzel


Journal of Medicinal Chemistry | 1997

Non-Peptide RGD Surrogates Which Mimic a Gly-Asp β-Turn: Potent Antagonists of Platelet Glycoprotein IIb−IIIa

Matthew Fisher; Bruce P. Gunn; Cathy S. Harms; Allen D. Kline; Jeffrey Thomas Mullaney; Anne Nunes; Robert M. Scarborough; Ann E. Arfsten; Marshall Alan Skelton; Suzane L. Um; Barbara G. Utterback; Joseph A. Jakubowski


Archive | 2000

Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists

Karin Briner; Joseph Paul Burkhart; Timothy Paul Burkholder; Matthew Joseph Fisher; William Harlan Gritton; Daniel Timothy Kohlman; Sidney Xi Liang; Shawn Christopher Miller; Jeffrey Thomas Mullaney; Yao-Chang Xu; Yanping Xu


Bioorganic & Medicinal Chemistry Letters | 2005

Privileged structure-based ligands for melanocortin receptors—tetrahydroquinolines, indoles, and aminotetralines

Matthew Joseph Fisher; Ryan T. Backer; Saba Husain; Hansen M. Hsiung; Jeffrey Thomas Mullaney; Thomas P. O’Brian; Paul L. Ornstein; Roger Ryan Rothhaar; John M. Zgombick; Karin Briner


Bioorganic & Medicinal Chemistry Letters | 2006

Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor

Qing Shi; Paul L. Ornstein; Karin Briner; Timothy I. Richardson; Macklin Brian Arnold; Ryan T. Backer; Jennifer L. Buckmaster; Emily J. Canada; Christopher W. Doecke; Larry Wayne Hertel; Nick Honigschmidt; Hansen M. Hsiung; Saba Husain; Steve L. Kuklish; Michael J. Martinelli; Jeffrey Thomas Mullaney; Thomas P. O’Brien; Matt R. Reinhard; Roger Ryan Rothhaar; Jikesh Shah; Zhipei Wu; Chaoyu Xie; John M. Zgombick; Matthew Joseph Fisher

Collaboration


Dive into the Jeffrey Thomas Mullaney's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge